Sign In
Buy HIMS
$27.77
+0.730 (+2.70%)
At Close: Jul 31, 2026
Hims & Hers Stock Plunges After Q1 Miss: Is the GLP-1 Pivot Enough to Fuel a Recovery?
01:00pm, Tuesday, 12'th May 2026
Shares of telehealth provider Hims & Hers Health NYSE: HIMS sold off sharply following disappointing Q1 FY2026 financial results, with shares falling more than 12% in after-hours trading after the com
Hims & Hers Stock Plunges Post Q1 Earnings Miss, Gross Margin Down
12:47pm, Tuesday, 12'th May 2026
HIMS reports an adjusted loss and a revenue miss in first-quarter 2026 as gross margin decreases, but it lifts its full-year revenue outlook.
Tech Selloff, Inflation Woes Trigger Broader Market Pullback
11:57am, Tuesday, 12'th May 2026
All three major indexes are pulling back as crude prices continue to rise into triple-digit territory
Hims & Hers shares plummet on first quarter earnings miss
11:50am, Tuesday, 12'th May 2026
Hims & Hers (NYSE:HIMS) reported first quarter financial results that included a wider-than-expected loss and softer revenue performance, sending shares down nearly 14% to about $25 on Tuesday mornin
Why Hims & Hers Health Stock Just Crashed
11:32am, Tuesday, 12'th May 2026
Hims and Hers is unshaken by its earnings miss, with management promising even faster sales growth this year.
Hims & Hers Drops After Earnings Miss & HIMS Options Trade
11:30am, Tuesday, 12'th May 2026
Marley Kayden breaks down Him & Hers (HIMS) after the company missed on both earnings and revenue. She explains how the end of the weight-loss drug shortage hurt their momentum, despite a rise in subs
JPMorgan Cuts Hims & Hers Price Target as GLP-1 Shift Reshapes the Growth Story
11:21am, Tuesday, 12'th May 2026
Shares of Hims & Hers Health (NYSE:HIMS) are under pressure after JPMorgan trimmed its price target on the consumer telehealth name following a messy first quarter.
The $59B Quiet Shift Reshaping How Patients Access Care
11:00am, Tuesday, 12'th May 2026
The $59B Quiet Shift Reshaping How Patients Access Care PR Newswire VANCOUVER, BC, May 12, 2026
Hims & Hers: I See No New Red Flags
08:55am, Tuesday, 12'th May 2026
Hims & Hers stock is crashing in pre-market trading, down about 14%, after reporting a disastrous Q1 and an upbeat Q2 outlook. We don't find Q1 weakness surprising due to the Novo deal timing and toug
U.S.-Iran Ceasefire on "Life Support," HIMS & ASTS Earnings Sell-Off
08:43am, Tuesday, 12'th May 2026
The U.S.-Iran ceasefire is on "life support," according to President Trump, causing stocks to slide and crude oil to climb in the overnight hours. Kevin Green explains how the geopolitical headlines c
5 Things to Know Before the Stock Market Opens
08:18am, Tuesday, 12'th May 2026
Stock futures are lower ahead of the release of a key inflation report, while oil prices rise amid a lack of progress in talks to end the Iran war; the Consumer Price Index for April is expected to sh
Hims & Hers tumbles 15% after earnings miss as GLP-1 transition weighs on results
07:48am, Tuesday, 12'th May 2026
Shares of Hims & Hers Health (HIMS) fell sharply in premarket trading on Tuesday after the telehealth company reported weaker-than-expected first-quarter revenue and a surprise loss. The stock dropped
Hims & Hers is going bigger on weight loss treatments
07:42am, Tuesday, 12'th May 2026
Hims and Hers Health (HIMS) is leaning harder into the booming weight loss market after raising its 2026 revenue forecast to as high as $3 billion and signaling c
Hims & Hers Miss Sparks Sharp Selloff
07:39am, Tuesday, 12'th May 2026
Hims and Hers Health (HIMS) fell 15.61% in pre-market trading after reporting Q1 2026 revenue of $608 million, up 4% year over year but below the $617 million Wal
Hims & Hers plummets 16% after first-quarter loss, weak earnings guidance
07:05am, Tuesday, 12'th May 2026
Digital health firm Hims & Hers' stock plummeted in premarket trading on weak first-quarter earnings. Hims reported a net loss of $92 million in the first quarter, up from $50 million last year.
